These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 8866657)
1. Gamma scintigraphy of a 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinoma. Pimm MV; Perkins AC; Strohalm J; Ulbrich K; Duncan R J Drug Target; 1996; 3(5):385-90. PubMed ID: 8866657 [TBL] [Abstract][Full Text] [Related]
2. Gamma scintigraphy of the biodistribution of 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in mice with transplanted melanoma and mammary carcinoma. Pimm MV; Perkins AC; Strohalm J; Ulbrich K; Duncan R J Drug Target; 1996; 3(5):375-83. PubMed ID: 8866656 [TBL] [Abstract][Full Text] [Related]
3. Targeting of N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate to the hepatocyte galactose-receptor in mice: visualisation and quantification by gamma scintigraphy as a basis for clinical targeting studies. Pimm MV; Perkins AC; Duncan R; Ulbrich K J Drug Target; 1993; 1(2):125-31. PubMed ID: 8069550 [TBL] [Abstract][Full Text] [Related]
4. Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells. David A; Kopecková P; Minko T; Rubinstein A; Kopecek J Eur J Cancer; 2004 Jan; 40(1):148-57. PubMed ID: 14687799 [TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments. Shiah JG; Sun Y; Peterson CM; Straight RC; Kopecek J Clin Cancer Res; 2000 Mar; 6(3):1008-15. PubMed ID: 10741728 [TBL] [Abstract][Full Text] [Related]
6. Using small-angle neutron scattering to study the solution conformation of N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates. Paul A; Vicent MJ; Duncan R Biomacromolecules; 2007 May; 8(5):1573-9. PubMed ID: 17419585 [TBL] [Abstract][Full Text] [Related]
7. PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination. Satchi-Fainaro R; Hailu H; Davies JW; Summerford C; Duncan R Bioconjug Chem; 2003; 14(4):797-804. PubMed ID: 12862433 [TBL] [Abstract][Full Text] [Related]
8. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect. Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257 [TBL] [Abstract][Full Text] [Related]
9. Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumours. Etrych T; Subr V; Laga R; Ríhová B; Ulbrich K Eur J Pharm Sci; 2014 Jul; 58():1-12. PubMed ID: 24632485 [TBL] [Abstract][Full Text] [Related]
10. N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice. Seymour LW; Ulbrich K; Wedge SR; Hume IC; Strohalm J; Duncan R Br J Cancer; 1991 Jun; 63(6):859-66. PubMed ID: 1648946 [TBL] [Abstract][Full Text] [Related]
11. Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy. Etrych T; Kovář L; Strohalm J; Chytil P; Ríhová B; Ulbrich K J Control Release; 2011 Sep; 154(3):241-8. PubMed ID: 21699933 [TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl) methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice. Peterson CM; Lu JM; Sun Y; Peterson CA; Shiah JG; Straight RC; Kopecek J Cancer Res; 1996 Sep; 56(17):3980-5. PubMed ID: 8752167 [TBL] [Abstract][Full Text] [Related]
13. The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia. Tomalova B; Sirova M; Rossmann P; Pola R; Strohalm J; Chytil P; Cerny V; Tomala J; Kabesova M; Rihova B; Ulbrich K; Etrych T; Kovar M J Control Release; 2016 Feb; 223():1-10. PubMed ID: 26708020 [TBL] [Abstract][Full Text] [Related]
14. Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic. Duncan R; Gac-Breton S; Keane R; Musila R; Sat YN; Satchi R; Searle F J Control Release; 2001 Jul; 74(1-3):135-46. PubMed ID: 11489490 [TBL] [Abstract][Full Text] [Related]
15. HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity. Etrych T; Subr V; Strohalm J; Sírová M; Ríhová B; Ulbrich K J Control Release; 2012 Dec; 164(3):346-54. PubMed ID: 22759979 [TBL] [Abstract][Full Text] [Related]
16. Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts. Shiah JJ; Sun Y; Peterson CM; Kopecek J J Control Release; 1999 Aug; 61(1-2):145-57. PubMed ID: 10469911 [TBL] [Abstract][Full Text] [Related]
17. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line. Kunath K; Kopecková P; Minko T; Kopecek J Eur J Pharm Biopharm; 2000 Jan; 49(1):11-5. PubMed ID: 10613922 [TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates. Luo Y; Bernshaw NJ; Lu ZR; Kopecek J; Prestwich GD Pharm Res; 2002 Apr; 19(4):396-402. PubMed ID: 12033370 [TBL] [Abstract][Full Text] [Related]
19. Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification. Chytil P; Etrych T; Konák C; Sírová M; Mrkvan T; Ríhová B; Ulbrich K J Control Release; 2006 Sep; 115(1):26-36. PubMed ID: 16899320 [TBL] [Abstract][Full Text] [Related]
20. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck. Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]